An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold

S Cherukupalli, R Karpoormath… - European journal of …, 2017 - Elsevier
Abstract Pyrazolo [1, 5-a] pyrimidine scaffold is one of the privileged hetrocycles in drug
discovery. Its application as a buliding block for developing drug-like candidates has …

An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold

S Cherukupalli, R Karpoormath… - European Journal of …, 2017 - hero.epa.gov
Abstract Pyrazolo [1, 5-a] pyrimidine scaffold is one of the privileged hetrocycles in drug
discovery. Its application as a buliding block for developing drug-like candidates has …

[PDF][PDF] An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold pp. 298e352

S Cherukupalli, R Karpoormath… - European Journal of …, 2017 - academia.edu
European Journal of Medicinal Chemistry Page 1 European Journal of Medicinal Chemistry
Vol 126, 2017 Graphical abstracts REVIEW ARTICLES An insight on synthetic and …

An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold

S Cherukupalli, R Karpoormath… - European journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Pyrazolo [1, 5-a] pyrimidine scaffold is one of the privileged hetrocycles in drug discovery. Its
application as a buliding block for developing drug-like candidates has displayed broad …

An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold.

S Cherukupalli, R Karpoormath… - European Journal of …, 2016 - europepmc.org
Pyrazolo [1, 5-a] pyrimidine scaffold is one of the privileged hetrocycles in drug discovery. Its
application as a buliding block for developing drug-like candidates has displayed broad …

An insight on synthetic and medicinal aspects of pyrazolo [1, 5-a] pyrimidine scaffold

S Cherukupalli, R Karpoormath… - European Journal of …, 2017 - infona.pl
Pyrazolo [1, 5-a] pyrimidine scaffold is one of the privileged hetrocycles in drug discovery. Its
application as a buliding block for developing drug-like candidates has displayed broad …